National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

gadopentetate dimeglumine
A gadolinium complex of diethylenetriamine pentaacetic acid with ionic paramagnetic properties. Gadopentetate dimeglumine may provide contrast enhancement during magnetic resonance imaging (MRI) of intracranial lesions with abnormal vascularity or of abnormalities in the blood-brain barrier (BBB). Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonym:gadolinium DTPA
US brand names:Magnevist
MultiHance
Abbreviation:Gd-DTPA



Previous:G250 peptide vaccine, Ga-68-labeled F(ab') 2- trastuzumab, gabapentin, gadobutrol, gadolinium-chelate
Next:Gadovist, galiximab, gallium citrate Ga 67, gallium Ga 68-DOTANOC, gallium nitrate

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov